Sort
50,496 grants matching “lung cancer”
Studies of Atomic Bomb Survivors
$760,886Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Improving Long-Term Physical and Mental Health after Acute Lung Injury
$760,834Peter J Pronovost · Johns Hopkins University · R01 · FY2008 · HL
Arsenic and the Human Genome: susceptibility and response to exposure
$760,753Brandon Lee Pierce · University Of Chicago · R35 · FY2020 · ES
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction
$760,707C. Noel Bairey Merz · Cedars-Sinai Medical Center · R01 · FY2011 · HL
Does Switching to Nicotine-containing Electronic Cigarettes Reduce Health Risk Markers?
$760,587Jonathan Foulds · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2021 · DA
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
$760,579Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2015 · CA
ENLACE: A Promotora-Led Physical Activity Intervention Trial for Latinas in Texas
$760,539Deborah M. Parra-Medina · University Of Texas Hlth Science Center · R01 · FY2012 · HL
The impact of illness and medical treatments on the alloantibody response to platelet transfusion
$760,351Rachael Peretz Jackman · Vitalant · R01 · FY2021 · HL
Genetic Epidemiology of Cancer
$760,199Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2013 · HG
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$760,163Sandra Aung · Ubivac, Llc · R44 · FY2009 · CA
NINDS Quantitative MRI Core Facility
$759,886Govind Nair · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS
Longitudinal Studies of HIV-Associated Lung Infections and Complications
$759,809Kristina Anne Crothers · University Of Washington · R01 · FY2009 · HL
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
$759,575Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2016 · CA
Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy
$759,465Ke Cheng · North Carolina State University Raleigh · R01 · FY2022 · HL
Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy
$759,465Ke Cheng · North Carolina State University Raleigh · R01 · FY2021 · HL
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
$759,429Susan Bates · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors
$759,285James F Kronauge · Cytosite Biopharma, Inc. · R44 · FY2019 · CA
Epstein-Barr Virus Associated Disorders
$759,114Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - W
$758,959Wayne State University · N01 · FY2000 · CN
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease
$758,850Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2020 · AI
The Epidemiology of the Weiss Cohort Project
$758,753Stanley H Weiss · Rbhs-New Jersey Medical School · R01 · FY2022 · DA
Clinical Cancer Genomics Program
$758,517Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$758,478Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Rational antibody therapy for IPF
$758,362Andrew R Mendelsohn · Panorama Research, Inc. · R44 · FY2018 · HL
Nanotechnology Platform for Targeting Solid Tumors
$758,182Mark A Talamini · University Of California, San Diego · R01 · FY2009 · CA